Wird geladen...

Efficacy of chemotherapy plus gefitinib treatment in advanced non-small-cell lung cancer patients following acquired resistance to gefitinib

Non-small-cell lung cancer (NSCLC) may exhibit oncogene addiction in patients who benefited from prior treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs). Preclinical data suggested that EGFR addiction persists after the development of TKI resistance, leading ma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SONG, ZHENGBO, ZHANG, YIPING
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2013
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3915312/
https://ncbi.nlm.nih.gov/pubmed/24649264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2013.156
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!